Sicilia M. (2024). Beyond Access: How Wealth and Race Shape GLP-1 Treatment Outcomes in Diabetes and Weight Loss. 

Rosenblatt J., Rosenberg R., Anand A. (2024). Using Longitudinal Claims Data to More Accurately Predict Response Uptake Curves in Rare & Ultra Rare Disease. [Theater Presentation] PMSA 2024. May 5-8. Denver, USA

Kuranz S. (2024). Emergency Room Utilization Among Multiple Sclerosis Patients Treated with Disease-Modifying Therapy in a Real-World Hybrid Claims Database. [Poster Presentation] ISPOR 2024. May 5-8. Atlanta, USA

Kuranz S., Westall T. (2024). Patterns of Treatment Initiation By Sarcoidosis Type in a Real-World Hybrid Claims Database. [Poster Presentation] ISPOR 2024. May 5-8. Atlanta, USA

Kuranz S. (2023). Progression to ESRD Among White, Black and Hispanic Diabetic Kidney Disease Patients: Real-World Evidence from Multiple Linked Claims Databases. [Abstract]. ICPE Annual Conference 2023. August 23-27. Halifax, Canada.

Zylla D, Knowlton G, Gilmore G, Pawloski PA, Salz T, Kulkarni AA, Cowger J, Kuranz S. (2023). Association of Cannabis Use with Real-World Time to Treatment Discontinuation in Advanced Cancer Patients Initiating Immune Checkpoint Inhibition. [Abstract]. ASCO Annual Meeting 2023. June 2-6. Chicago, USA.

Kuranz S., Neilson D. (2023). Real World Evidence on the Use of ECMO in Hospitalized COVID-19 Patients: Results From a Linked Closed and Open Claims Database in the US. [Poster Presentation] ISPOR 2023. May 7-10. Boston, USA

Kuranz S. (2023). Adherence and Persistence with SGLT-2 Inhibitors among White and Black Diabetic Kidney Disease Patients: Real-World Evidence From a Large US Claims Database. [Poster Presentation] ISPOR 2023. May 7-10. Boston, USA

Kuranz S., Neilson D., van der Pluijm W. (2023). Estimating the Cost of End-of-Life Care Among US Adults: Real-World Evidence Using a Case-Crossover Study Design. [Poster Presentation] ISPOR 2023. May 7-10. Boston, USA

Kuranz S., Anand A., van der Pluijm W. (2023). Real-world Evidence on the Association Between the Use of Cannabis and Healthcare Resource Utilization Among Patients With Chronic Post-Traumatic Stress Disorder. [Poster Presentation] ISPOR 2023. May 7-10. Boston, USA

Kuranz S., van der Pluijm W. (2022). The Cost of Care Among Infantile and Child Spinal Muscular Atrophy Patients: RWE From a Large Claims Database. [Poster Presentation] ISPOR Europe 2022. November 6-9. Vienna, Austria.

Fishman J., Hubbert A., van der Pluijm W., Zhang C., Sun An Y. (2022). Epidemiological Estimate of the Prevalence of the Coded Nonalcoholic Steatohepatitis (NASH) Population in the US Using an Administrative Claims Dataset. [Poster Presentation] ISPOR Europe 2022. November 6-9. Vienna, Austria.

Kuranz, S. (2023). Introduction to CHRONOS: Forian’s Hybrid Real-World Data Ecosystem.

Kuranz, S. (2023). Real-world Evidence Generation From Hybrid Claims Data: An Interview With Seth Kuranz, Forian Inc. The Evidence Base.

Rhyee, C. (Host). (2023, August 16). Understanding and Leveraging Healthcare Data with Paul Reuscher. [Audio podcast episode]. In TD Cowen Insights Podcase: FutureHealth Podcast Series.